Title of article :
Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation: The ARREST-AF Cohort Study
Author/Authors :
Pathak، نويسنده , , Rajeev K. and Middeldorp، نويسنده , , Melissa E. and Lau، نويسنده , , Dennis H. and Mehta، نويسنده , , Abhinav B. and Mahajan، نويسنده , , Rajiv and Twomey، نويسنده , , Darragh and Alasady، نويسنده , , Muayad and Hanley، نويسنده , , Lorraine and Antic، نويسنده , , Nicholas A. and McEvoy، نويسنده , , R. Doug and Kalman، نويسنده , , Jonathan M. and Abhayaratna، نويسنده , , Walter P. and Sanders، نويسنده , , Prashanthan، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2014
Pages :
10
From page :
2222
To page :
2231
Abstract :
AbstractBackground ng-term outcome of atrial fibrillation (AF) ablation demonstrates attrition. This outcome may be due to failure to attenuate the progressive substrate promoted by cardiovascular risk factors. ives al of this study was to evaluate the impact of risk factor and weight management on AF ablation outcomes. s consecutive patients undergoing AF ablation, 149 with a body mass index ≥27 kg/m2 and ≥1 cardiac risk factor were offered risk factor management (RFM) according to American Heart Association/American College of Cardiology guidelines. After AF ablation, all 61 patients who opted for RFM and 88 control subjects were assessed every 3 to 6 months by clinic review and 7-day Holter monitoring. Changes in the Atrial Fibrillation Severity Scale scores were determined. s were no differences in baseline characteristics, number of procedures, or follow-up duration between the groups (p = NS). RFM resulted in greater reductions in weight (p = 0.002) and blood pressure (p = 0.006), and better glycemic control (p = 0.001) and lipid profiles (p = 0.01). At follow-up, AF frequency, duration, symptoms, and symptom severity decreased more in the RFM group compared with the control group (all p < 0.001). Single-procedure drug-unassisted arrhythmia-free survival was greater in RFM patients compared with control subjects (p < 0.001). Multiple-procedure arrhythmia-free survival was markedly better in RFM patients compared with control subjects (p < 0.001), with 16% and 42.4%, respectively, using antiarrhythmic drugs (p = 0.004). On multivariate analysis, type of AF (p < 0.001) and RFM (hazard ratio 4.8 [95% confidence interval: 2.04 to 11.4]; p < 0.001) were independent predictors of arrhythmia-free survival. sions sive RFM improved the long-term success of AF ablation. This study underscores the importance of therapy directed at the primary promoters of the AF substrate to facilitate rhythm control strategies.
Keywords :
Cardiac risk factors , Follow-Up Studies , Obesity , outcomes remodeling , catheter ablation
Journal title :
JACC (Journal of the American College of Cardiology)
Serial Year :
2014
Journal title :
JACC (Journal of the American College of Cardiology)
Record number :
1759649
Link To Document :
بازگشت